ImmunologybioRxivPreprint
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike
C. Graham, J. Seow, I. Huettner…·K. J. Doores
This study examines how mutations in the B.1.1.7 variant of SARS-CoV-2 affect neutralization by monoclonal antibodies targeting non-RBD epitopes.
DOI 10.1101/2021.02.03.429355